CASE STUDY

Category Market Intelligence Assists a Renowned Biosimilar Drugs Manufacturer to Understand the Competitive Scenario and Effectively Strategize their Decision-making Process

Mar 29, 2018

Overview of the Biotech Industry

The global investment in biotechnology has increased consistently, owing to the growing demand for medical applications that offer cost-effective care for the aging global population. To establish their presence in this competitive environment, prominent biotech companies are planning to invest heavily in advanced medicines such as biosimilar drugs to combat chronic diseases such as cancer and diabetes. The cost of biosimilars is 10-30% lesser than their parent products; thus, compelling businesses to invest highly in research and development to diversify their business models and offer reliable and cost-effective services to the customers.

Although biosimilar drugs are gaining traction among the end-user segments, several factors may hinder the growth of the industry. They include:

  • Rising regulatory concerns: In recent years, biotech companies have been compelled to comply with the regulatory guidelines set forth by the Food and Drug Administration. With the fluctuating changes in regulatory requirements, it becomes necessary for the biotech companies to stay relevant and keep-up-to-date with the legislative changes and ensure that they meet all the requirements.
  • Contract manufacturing: With the demand outpacing the production capabilities, several biotech companies have started outsourcing their production capabilities to reduce capital and outlay costs. However, companies face several uncertainties when it comes to meeting the quality standards while ensuring consistency in their product offerings.
  • Innovations: The intense competition in the biotech industry is augmenting the need to stay relevant and keep pace with the latest developments. Moreover, developing products is an expensive and time-consuming affair and requires high investments.

With the increasing competition in the biotech industry, biotech companies are facing the need to invest highly in their technical capabilities to reduce the risks associated with the supply and further ensure quality in their product offerings. To tackle challenges and bridge the demand-supply gap, biosimilar drugs manufacturers should also understand who their target audiences are and their preferences toward the products.request free proposal

The Business Challenge and the Solution Offered

A renowned biosimilar drugs manufacturer wanted to understand the current market scenario and analyze the latest trends and developments in the market. The biosimilar drugs manufacturer wanted to gain timely and relevant insights into the competitors, their product offerings, and devise an effective market plan to meet the growing preferences of the customers. With the help of an effective market intelligence solution, the biosimilar drugs manufacturer wanted to gain information on the cost and the market dynamics including raw material prices, indirect spend, and logistics expenses.

To identify the early warning signs of potential problems and mitigate potential risks in the supply chain, the procurement experts at SpendEdge carried out an extensive research. The methodology focused on interviews and discussions with prominent stakeholders in the biosimilar drugs manufacturing space. The experts also compiled information across various secondary sources to gain robust and predictive procurement intelligence.

The market intelligence solution offered by SpendEdge offered insightful ways for the biosimilar drugs manufacturer to assess the current market dynamics, drivers, and challenges. The firm was able to create a SWOT analysis to identify the barriers, opportunities, and market trends and devise effective procurement best practices to mitigate these potential risks.

Fundamental questions answered in this market intelligence study for biosimilar drugs include:

SP00


The Results

The engagement offered by SpendEdge helped the biosimilar drugs manufacturer gain a deep-dive knowledge on the supplier pricing, the cost structure, and the technology landscape. The category market intelligence engagement also helped biotech products manufacturer achieve operational efficiency while addressing the supplier diversity for the products offered.


To know more about our category market intelligence solution for biosimilar drugs manufacturer

request free proposal


Related posts:

Recent Case Studies

Industries

Services

Getting Down To Business

We are offering Free Trials to all our customers or prospects who have been impacted positively or negatively by Covid-19 and are looking to connect with prospect buyers immediately.

Contact us

Sourcing and Procurement Market Intelligence Services

Products and Tools

Featured

Services Overview

Category Market Intelligence

Supply Market Analysis

Low-Cost/Best-Cost Country Sourcing

Benchmarking

Spend Analysis

Cost Modeling and Should-Cost Analysis

Total Cost of Ownership (TCO) Analysis

Supplier Risk Analysis

Supply Chain Risk Assessment

Supplier Sustainability Assessment

Commodity Price Forecasting

Category Management

Supplier Negotiations

Contract Management

Procurement Store

Purchase Ready-to-use Reports

SEinsightsTM

Our Robust Procurement Platform

BizVibeTM

Suppliers and Buyers Marketplace

SUPPLY MARKET ANALYSIS FOR A METAL MANUFACTURING COMPANY HELPS ACHIEVE ANNUAL SAVINGS OF $15 MILLION

Industries

Industries Overview

Automotive and Tire

Banking, Financial Services and Insurance

Biotechnology, Pharmaceutical and Life Sciences

Chemicals

Energy

Food and Beverage

Industrial and Manufacturing

ICT, Media and Entertainment

Mining, Metals and Minerals

Retail and CPG

Transportation

INCREASING LOCAL PROCUREMENT BY 28% FOR A COMPANY IN THE METALS AND MINING INDUSTRY – A CASE STUDY BY SPENDEDGE

Resources

Featured

Resources Overview

COVID-19 Resources

Blogs

Case Studies

Whitepapers

Webinars

Press Releases and Media Mentions

5 KEY CORONAVIRUS RISK ASSESSMENT STRATEGIES TO OVERCOME HEALTHCARE SUPPLY CHAIN CHALLENGES

IDENTIFYING STRATEGIC PURCHASING PRACTICES FOR A COMPANY IN THE US FOOD SERVICE INDUSTRY | SPENDEDGE’S LATEST SUCCESS STORY

COVID-19

Featured

Overview

Buyers

Diagnostic Test Kit

Additional Resources
Contact

A LOOK INTO THE FUTURE OF THE FOOD AND BEVERAGE INDUSTRY AFTER THE COVID-19 PANDEMIC

Identifying the Top 100 Coronavirus (COVID-19) Test Kit Manufacturers Across Regions

Clients

Featured

Clients Overview

Who We Serve

Case Studies

SUPPLY CHAIN MANAGEMENT HELPS AN IMPORT AND EXPORT INDUSTRY CLIENT ENHANCE SUPPLY CHAIN VISIBILITY

REALIZING SAVINGS OF $15 MILLION IN PACKAGING SPEND FOR AN FMCG CLIENT – PACKAGING SOURCING STRATEGY

About Us

News

About SpendEdge
Why SpendEdge?
Vision, Mission and Values
Clients
Social Impact
Global Offices

Press Releases and Media Mentions

Upcoming Events & Webinars